Ionis Pharmaceuticals (IONS) Tops Q3 EPS by 17c
Tweet
Share
E-mailGet Alerts IONS Hot Sheet
Join SI Premium – FREE
Ionis Pharmaceuticals (NASDAQ: IONS) reported Q3 EPS of ($0.95), $0.17 better than the analyst estimate of ($1.12). Revenue for the quarter came in at $134 million versus the consensus estimate of $129.33 million.
For earnings history and earnings-related data on Ionis Pharmaceuticals (IONS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Mercer Int'l (MERC) Misses Q2 EPS by 53c
- Morgan Stanley Upgrades Roche Holding (ROG:SW) (RHHBY) to Overweight
- Citizens Upgrades RXO, Inc. (RXO) to Market Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
